PFO closure with only fluoroscopic guidance: 7 years real‐world single centre experience
- 8 November 2014
- journal article
- pediatric and-congenital-heart-disease
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 86 (1) , 105-112
Abstract
Aims: To evaluate the safety and the efficacy of fluoroscopy‐guided only (Fluo‐G) and of echocardiography‐guided (Echo‐G; trans‐esophageal echocardiography—TEE—or intracardiac echocardiography‐ICE) percutaneous closure of patent foramen ovale (PFO).Methods and Results: Single center retrospective registry enrolling 368 consecutive patients (mean age 50.5 years) who underwent PFO closure between June 2004 and December 2011. Most patients had prior cryptogenic stroke (n = 126; 34.2%), TIA (n = 218; 51.1%); some of these had recurrent neurological events [multiple strokes n = 28 (7.8%); multiple TIAs n = 72 (18.6%)]. All the patients underwent a preprocedure TEE. PFO closure was performed with Echo‐G in 187 patients (50.8%) (TEE n = 69, 36.8% and ICE n = 124, 66.3%). In Fluo‐G cases, PFO with atrial septal aneurysm (ASA) was significantly less present (P < 0.005) and smaller devices (P < 0.001). Both fluoroscopy and total procedural time were lower in the Fluo‐G group (P < 0.0001). No differences were found in terms of successful device deployment (98.3% Fluo‐G vs. 98.3% Echo‐G) and RtL‐shunt at follow‐up (11.7% Fluo‐G vs. 7.6% Echo‐G). The rate of conversion from Fluoro‐G to Echo‐G procedure was 4.4% (n = 8). At a median follow‐up of 4 years, freedom from recurrent embolic events rate was similar between the two groups (Echo‐G 94.5 vs. Fluo‐G 95.7%).Conclusions: In our experience Fluoro‐G PFO closure was performed mainly in cases of simple anatomy, with similar results in terms of safety and efficacy compared to Echo‐G cases. Both fluoroscopy and total procedural times were lower in the Fluo‐G cases.Keywords
This publication has 19 references indexed in Scilit:
- Paradoxical EmbolismJACC, 2014
- Closure of the Patent Foramen OvaleJACC: Cardiovascular Interventions, 2013
- Long-Term Experience and Outcomes With Transcatheter Closure of Patent Foramen OvaleJACC: Cardiovascular Interventions, 2013
- Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic StrokeNew England Journal of Medicine, 2013
- Percutaneous Closure of Patent Foramen Ovale in Cryptogenic EmbolismNew England Journal of Medicine, 2013
- Still No Closure on the Question of PFO ClosureNew England Journal of Medicine, 2013
- Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen OvaleNew England Journal of Medicine, 2012
- Patent Foramen Ovale Closure Without Echocardiographic Control: Use of “Standby” Intracardiac UltrasoundJACC: Cardiovascular Interventions, 2008
- Diagnosis of an Anatomically and Physiologically Significant Patent Foramen OvaleEchocardiography, 2006
- Atrial septal aneurysm and stroke: A transesophageal echocardiographic studyJACC, 1991